Boudreau Philip P's Form 4 filing
Abbott Laboratories (ABT) · filed Jun 20, 2023
- Accession no.
- 0001415889-23-010065
- Filed
- Jun 20, 2023
- Trade date
- Jun 16, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $848.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boudreau Philip PCIK 0001805099 | Officer (VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2023 | Common shares without par value | SSaleDisposed | −8,000 | $106.00 | −$848,000 | 15,447 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.